Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 21.64
+1.34 (6.60%)
Oct 26, 2026, 12:24 PM CET
Kuros Biosciences AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 860 | 1,076 | 806 | 128 | 54 | 63 | |
Market Cap Growth | -30.78% | 33.55% | 528.00% | 138.81% | -14.90% | -4.70% |
Enterprise Value | 861 | 1,063 | 793 | 114 | 34 | 38 |
Last Close Price | 20.30 | 27.48 | 21.35 | 3.49 | 1.47 | 1.93 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 122.98 | 531.92 | - | - | - | - |
Forward PE | 56.18 | 80.23 | - | - | - | - |
PS Ratio | 5.71 | 9.29 | 10.44 | 3.82 | 2.99 | 4.57 |
PB Ratio | 11.19 | 16.06 | 13.80 | 2.26 | 0.78 | 0.82 |
P/TBV Ratio | 19.83 | 31.13 | 33.33 | 8.15 | 2.67 | 3.01 |
P/FCF Ratio | - | - | 385.54 | - | - | - |
P/OCF Ratio | - | - | 251.14 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.71 | 9.18 | 10.28 | 3.41 | 1.90 | 2.77 |
EV/EBITDA Ratio | 69.98 | 116.34 | 377.84 | - | - | - |
EV/EBIT Ratio | 94.06 | 149.76 | 7295.50 | - | - | - |
EV/FCF Ratio | - | - | 379.64 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.11 | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 |
Debt / EBITDA Ratio | 0.71 | 0.11 | 0.64 | - | - | - |
Debt / FCF Ratio | - | - | 0.85 | - | - | - |
Net Debt / Equity Ratio | 0.00 | -0.22 | -0.28 | -0.21 | -0.32 | -0.34 |
Net Debt / EBITDA Ratio | 0.03 | -1.59 | -7.68 | 4.04 | 2.95 | 4.17 |
Net Debt / FCF Ratio | -0.04 | 6.35 | -7.72 | 1.32 | 2.86 | 4.58 |
Asset Turnover | 1.35 | 1.29 | 0.99 | 0.44 | 0.21 | 0.15 |
Inventory Turnover | 1.03 | 1.17 | 1.21 | 1.27 | 1.47 | 2.33 |
Quick Ratio | 1.22 | 1.42 | 1.64 | 2.22 | 2.20 | 2.72 |
Current Ratio | 1.87 | 1.96 | 2.14 | 2.77 | 2.49 | 2.91 |
Return on Equity (ROE) | 10.73% | 3.31% | -6.59% | -16.18% | -20.02% | -9.33% |
Return on Assets (ROA) | 5.13% | 4.94% | 0.09% | -4.12% | -7.06% | -5.90% |
Return on Invested Capital (ROIC) | 9.81% | 7.80% | 0.24% | -11.67% | -20.09% | -15.80% |
Return on Capital Employed (ROCE) | 10.20% | 9.80% | 0.20% | -8.20% | -14.00% | -11.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.81% | 0.19% | -0.54% | -10.70% | -27.17% | -11.95% |
FCF Yield | -0.87% | -0.21% | 0.26% | -7.14% | -14.41% | -9.13% |
Buyback Yield / Dilution | 9.33% | -11.26% | -1.69% | -7.91% | -3.37% | -34.86% |